Craig-Hallum Upgrades Rezolute to Buy, Raises Price Target to $7
9/29/2026
Impact: 70
Healthcare
Craig-Hallum analyst Albert Lowe has upgraded Rezolute (NASDAQ: RZLT) from a Hold to a Buy rating. The price target for the stock has been raised from $4 to $7.
AI summary, not financial advice
Share: